{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:51:48Z","timestamp":1794253908965,"version":"4.9.0"},"reference-count":134,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Obesity is a major global health problem and is closely associated with a broad range of metabolic disorders, including metabolic syndrome (MetS), dyslipidemia, hypertension, atherosclerosis, type 2 diabetes mellitus, and cardiovascular disease. The gut microbiota plays a central role in maintaining intestinal epithelial integrity, regulating glucose and lipid metabolism, and modulating immune function. Through the gut\u2013brain axis, it also contributes to appetite regulation and energy homeostasis by influencing the release of anorexigenic hormones. Dysbiosis, including alterations in the relative abundance of major bacterial phyla such as Firmicutes and Bacteroidetes, has been associated with increased intestinal permeability, metabolic endotoxemia, and chronic low-grade inflammation, all of which may contribute to the development of obesity and insulin resistance. Diets rich in plant-derived fiber can beneficially shape gut microbiota composition. Bacterial fermentation of dietary fiber produces short-chain fatty acids (SCFAs), including butyrate, acetate, and propionate, which contribute to intestinal barrier integrity, inflammatory regulation, immune regulation, and metabolic homeostasis. Overall, the interaction between gut microbiota, diet, and host metabolic pathways represents a promising field for therapeutic and nutritional interventions aimed at preventing and managing MetS and metabolic diseases.<\/jats:p>","DOI":"10.3390\/biology15141115","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:46:47Z","timestamp":1783676807000},"page":"1115","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut Microbiota and Metabolic Syndrome: A Narrative Review"],"prefix":"10.3390","volume":"15","author":[{"given":"Ioanna","family":"Kotsiri","sequence":"first","affiliation":[{"name":"Second Department of Internal Medicine, Asklepieion General Hospital Voulas, 16673 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Prokou","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Asklepieion General Hospital Voulas, 16673 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampia Melangeli","family":"Domazinaki","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Asklepieion General Hospital Voulas, 16673 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Papadakaki","sequence":"additional","affiliation":[{"name":"Second Department of Internal Medicine, Asklepieion General Hospital Voulas, 16673 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8883-7275","authenticated-orcid":false,"given":"Emmanouil","family":"Magiorkinis","sequence":"additional","affiliation":[{"name":"Department of Laboratory Haematology, Metaxa Anticancer Memorial Hospital, 18537 Pireas, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100375","DOI":"10.1016\/j.metop.2025.100375","article-title":"Obesity: Prevalence, causes, consequences, management, preventive strategies and future research directions","volume":"27","author":"Ahmed","year":"2025","journal-title":"Metabol. Open"},{"key":"ref_2","first-page":"33","article-title":"The Role of Gut Microbiota in Obesity","volume":"63","author":"Durma","year":"2024","journal-title":"Adv. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s13098-024-01561-z","article-title":"Understanding the complex function of gut microbiota: Its impact on the pathogenesis of obesity and beyond: A comprehensive review","volume":"16","author":"Yarahmadi","year":"2024","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: Mechanistic insights","volume":"71","author":"Tilg","year":"2022","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Green, M., Arora, K., and Prakash, S. (2020). Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21082890"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12263-021-00703-6","article-title":"Gut microbiota in patients with obesity and metabolic disorders\u2014A systematic review","volume":"17","author":"Xu","year":"2022","journal-title":"Genes Nutr."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hernandez, M.A.G., Canfora, E.E., Jocken, J.W.E., and Blaak, E.E. (2019). The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. Nutrients, 11.","DOI":"10.3390\/nu11081943"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Agusti, A., Garcia-Pardo, M.P., Lopez-Almela, I., Campillo, I., Maes, M., Romani-Perez, M., and Sanz, Y. (2018). Interplay Between the Gut-Brain Axis, Obesity and Cognitive Function. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00155"},{"key":"ref_9","first-page":"7813537","article-title":"A Comparison of the Prevalence of the Metabolic Syndrome among Sri Lankan Patients with Type 2 Diabetes Mellitus Using WHO, NCEP-ATP III, and IDF Definitions","volume":"2018","author":"Herath","year":"2018","journal-title":"Int. J. Chronic Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 285, 2486\u20132497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kassi, E., Pervanidou, P., Kaltsas, G., and Chrousos, G. (2011). Metabolic syndrome: Definitions and controversies. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-48"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"320176","DOI":"10.1155\/2013\/320176","article-title":"A Comparison between Revised NCEP ATP III and IDF Definitions in Diagnosing Metabolic Syndrome in an Urban Sri Lankan Population: The Ragama Health Study","volume":"2013","author":"Chackrewarthy","year":"2013","journal-title":"ISRN Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Mohammad, S., and Thiemermann, C. (2020). Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.594150"},{"key":"ref_20","first-page":"61","article-title":"Understanding the role of the human gut microbiome in overweight and obesity","volume":"1540","author":"McBurney","year":"2024","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4161\/gmic.19897","article-title":"Microbial degradation of complex carbohydrates in the gut","volume":"3","author":"Flint","year":"2012","journal-title":"Gut Microbes"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"101118","DOI":"10.1016\/j.fochx.2024.101118","article-title":"Resistant starch and the gut microbiome: Exploring beneficial interactions and dietary impacts","volume":"21","author":"Chen","year":"2024","journal-title":"Food Chem. X"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1194\/jlr.R036012","article-title":"The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism","volume":"54","author":"Groen","year":"2013","journal-title":"J. Lipid Res."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cheng, Z., Zhang, L., Yang, L., and Chu, H. (2022). The critical role of gut microbiota in obesity. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1025706"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.ATV.0000251608.09329.9a","article-title":"Role of the Toll-like receptor 4\/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages","volume":"27","author":"Suganami","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Phuong-Nguyen, K., McNeill, B.A., Aston-Mourney, K., and Rivera, L.R. (2023). Advanced Glycation End-Products and Their Effects on Gut Health. Nutrients, 15.","DOI":"10.3390\/nu15020405"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Snelson, M., and Coughlan, M.T. (2019). Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology. Nutrients, 11.","DOI":"10.3390\/nu11020215"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1700118","DOI":"10.1002\/mnfr.201700118","article-title":"Dietary advanced glycation end products modify gut microbial composition and partially increase colon permeability in rats","volume":"61","author":"Qu","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"101734","DOI":"10.1016\/j.molmet.2023.101734","article-title":"Dietary Advanced Glycation End. products interacting with the intestinal epithelium: What do we really know?","volume":"73","author":"Jansen","year":"2023","journal-title":"Mol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Dong, H., Zhang, Y., Huang, Y., and Deng, H. (2022). Pathophysiology of RAGE in inflammatory diseases. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.931473"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/DMSO.S346411","article-title":"Dietary Advanced Glycation End Products Shift the Gut Microbiota Composition and Induce Insulin Resistance in Mice","volume":"15","author":"Wang","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3892\/ijmm.2023.5247","article-title":"Role of gut microbiota in the modulation of the health effects of advanced glycation end-products (Review)","volume":"51","author":"Aschner","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Machate, D.J., Figueiredo, P.S., Marcelino, G., Guimaraes, R.C.A., Hiane, P.A., Bogo, D., Pinheiro, V.A.Z., Oliveira, L.C.S., and Pott, A. (2020). Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114093"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e2020322118","DOI":"10.1073\/pnas.2020322118","article-title":"Microbiome signatures of progression toward celiac disease onset in at-risk children in a longitudinal prospective cohort study","volume":"118","author":"Leonard","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ccell.2018.03.004","article-title":"The Intestinal Microbiota in Colorectal Cancer","volume":"33","author":"Tilg","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","article-title":"Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease","volume":"25","author":"Loomba","year":"2017","journal-title":"Cell Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ismej.2012.153","article-title":"An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice","volume":"7","author":"Fei","year":"2013","journal-title":"ISME J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3164\/jcbn.15-152","article-title":"Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population","volume":"59","author":"Andoh","year":"2016","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.3748\/wjg.v30.i16.2249","article-title":"Association between childhood obesity and gut microbiota: 16S rRNA gene sequencing-based cohort study","volume":"30","author":"Li","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Zhang, S., and Dang, Y. (2022). Roles of gut microbiota and metabolites in overweight and obesity of children. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.994930"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1007\/s10620-013-2744-4","article-title":"Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity","volume":"58","author":"Soldavini","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Portincasa, P., Bonfrate, L., Vacca, M., De Angelis, M., Farella, I., Lanza, E., Khalil, M., Wang, D.Q., Sperandio, M., and Di Ciaula, A. (2022). Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031105"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/19490976.2015.1134082","article-title":"Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism","volume":"7","author":"Morrison","year":"2016","journal-title":"Gut Microbes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"G440","DOI":"10.1152\/ajpgi.00098.2010","article-title":"Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation","volume":"299","author":"Ellis","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s42000-019-00100-0","article-title":"From gut microbiota dysfunction to obesity: Could short-chain fatty acids stop this dangerous course?","volume":"18","author":"Barrea","year":"2019","journal-title":"Hormones"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","article-title":"Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate","volume":"579","author":"Zhao","year":"2020","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","article-title":"The Gut Microbiota in Prediabetes and Diabetes: A Population-Based Cross-Sectional Study","volume":"32","author":"Wu","year":"2020","journal-title":"Cell Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00125-019-4848-7","article-title":"Metformin-induced changes of the gut microbiota in healthy young men: Results of a non-blinded, one-armed intervention study","volume":"62","author":"Bryrup","year":"2019","journal-title":"Diabetologia"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.4345","article-title":"Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug","volume":"23","author":"Wu","year":"2017","journal-title":"Nat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/dc20-2257","article-title":"Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial","volume":"44","author":"Mueller","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40200-024-01435-1","article-title":"The impact of sodium-glucose cotransporter inhibitors on gut microbiota: A scoping review","volume":"23","author":"Afsar","year":"2024","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"sfaf351","DOI":"10.1093\/ckj\/sfaf351","article-title":"Gut microbiota modulation in GLP-1RA and SGLT-2i therapy: Clinical implications and mechanistic insights in type 2 diabetes","volume":"18","author":"Kanbay","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"159234","DOI":"10.1016\/j.bbalip.2022.159234","article-title":"Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota","volume":"1867","author":"Deng","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mindrescu, N.M., Guja, C., Jinga, V., Ispas, S., Curici, A., Nelson Twakor, A., and Pantea Stoian, A.M. (2024). Interactions between Gut Microbiota and Oral Antihyperglycemic Drugs: A Systematic Review. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063540"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gofron, K.K., Wasilewski, A., and Malgorzewicz, S. (2025). Effects of GLP-1 Analogues and Agonists on the Gut Microbiota: A Systematic Review. Nutrients, 17.","DOI":"10.3390\/nu17081303"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.3748\/wjg.v30.i43.4682","article-title":"Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy","volume":"30","author":"Basaranoglu","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jnutbio.2018.07.009","article-title":"Liraglutide modulates gut microbiota and reduces NAFLD in obese mice","volume":"62","author":"Moreira","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zhao, L., Qiu, Y., Zhang, P., Wu, X., Zhao, Z., Deng, X., Yang, L., Wang, D., and Yuan, G. (2022). Gut microbiota mediates positive effects of liraglutide on dyslipidemia in mice fed a high-fat diet. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1048693"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20171965","article-title":"Bile acids in glucose metabolism in health and disease","volume":"215","author":"Shapiro","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1475-2891-11-22","article-title":"Gut-central nervous system axis is a target for nutritional therapies","volume":"11","author":"Pimentel","year":"2012","journal-title":"Nutr. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.cmet.2021.05.002","article-title":"Gut-brain communication by distinct sensory neurons differently controls feeding and glucose metabolism","volume":"33","author":"Borgmann","year":"2021","journal-title":"Cell Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cell.2019.10.031","article-title":"Genetic Identification of Vagal Sensory Neurons That Control Feeding","volume":"179","author":"Bai","year":"2019","journal-title":"Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.regpep.2007.08.024","article-title":"The vagus nerve, food intake and obesity","volume":"149","author":"Berthoud","year":"2008","journal-title":"Regul. Pept."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.coph.2013.09.007","article-title":"Enteroendocrine cell signalling via the vagus nerve","volume":"13","author":"Dockray","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Li, H.Y., Zhou, D.D., Gan, R.Y., Huang, S.Y., Zhao, C.N., Shang, A., Xu, X.Y., and Li, H.B. (2021). Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients, 13.","DOI":"10.3390\/nu13093211"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ahmed, N., Gaur, V., Kamle, M., Chauhan, A., Chauhan, R., Kumar, P., and Singh, N.A. (2025). Microbiome-based therapeutics for metabolic disorders: Harnessing microbial intrusions for treatment. Front. Med. Technol., 7.","DOI":"10.3389\/fmedt.2025.1695329"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Chen, T., Wang, J., Liu, Z., and Gao, F. (2023). Effect of supplementation with probiotics or synbiotics on cardiovascular risk factors in patients with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1282699"},{"key":"ref_75","first-page":"e92881","article-title":"Efficacy of Gut Microbiome-Targeted Therapies in Modulating Systemic Inflammation and Low-Grade Chronic Inflammatory States in Adults with Metabolic Disorders: A Systematic Review","volume":"17","author":"Desoky","year":"2025","journal-title":"Cureus"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Plaza-Diaz, J., Herrera-Quintana, L., Olivares-Arancibia, J., and Vazquez-Lorente, H. (2026). Personalized Nutrition Through the Gut Microbiome in Metabolic Syndrome and Related Comorbidities. Nutrients, 18.","DOI":"10.3390\/nu18020290"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.chom.2018.05.012","article-title":"The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease","volume":"23","author":"Makki","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Cronin, P., Joyce, S.A., O\u2019Toole, P.W., and O\u2019Connor, E.M. (2021). Dietary Fibre Modulates the Gut Microbiota. Nutrients, 13.","DOI":"10.3390\/nu13051655"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Garcia-Mantrana, I., Selma-Royo, M., Alcantara, C., and Collado, M.C. (2018). Shifts on Gut Microbiota Associated to Mediterranean Diet Adherence and Specific Dietary Intakes on General Adult Population. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.00890"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa","volume":"107","author":"Cavalieri","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.tjnut.2022.12.017","article-title":"Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity","volume":"153","author":"Igudesman","year":"2023","journal-title":"J. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"E9499","DOI":"10.1073\/pnas.1806635115","article-title":"ACSS2 promotes systemic fat storage and utilization through selective regulation of genes involved in lipid metabolism","volume":"115","author":"Huang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1002\/edm2.436","article-title":"Human. gut microbiome: Therapeutic opportunities for metabolic syndrome-Hype or hope?","volume":"7","author":"Horvath","year":"2024","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0007114510003363","article-title":"Prebiotic effects: Metabolic and health benefits","volume":"104","author":"Roberfroid","year":"2010","journal-title":"Br. J. Nutr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/nutrit\/nuw039","article-title":"Effects of probiotic supplementation in patients with type 2 diabetes: Systematic review and meta-analysis","volume":"74","author":"Akbari","year":"2016","journal-title":"Nutr. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.diabres.2016.06.014","article-title":"Probiotics for the management of type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"118","author":"Samah","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e017995","DOI":"10.1136\/bmjopen-2017-017995","article-title":"Impact of bacterial probiotics on obesity, diabetes and non-alcoholic fatty liver disease related variables: A systematic review and meta-analysis of randomised controlled trials","volume":"9","author":"Koutnikova","year":"2019","journal-title":"BMJ Open"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Mederle, A.L., Dima, M., Stoicescu, E.R., Capastraru, B.F., Levai, C.M., Hategan, O.A., and Maghiari, A.L. (2024). Impact of Gut Microbiome Interventions on Glucose and Lipid Metabolism in Metabolic Diseases: A Systematic Review and Meta-Analysis. Life, 14.","DOI":"10.3390\/life14111485"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.clnu.2021.05.027","article-title":"Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: A systematic review and meta-analysis of randomized clinical trials","volume":"40","author":"Hadi","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"100810","DOI":"10.1016\/j.crfs.2024.100810","article-title":"Impact of probiotics on weight loss, glucose and lipid metabolism in overweight or obese women: A meta-analysis of randomized controlled trials","volume":"9","author":"Cao","year":"2024","journal-title":"Curr. Res. Food Sci."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Tenorio-Jimenez, C., Martinez-Ramirez, M.J., Gil, A., and Gomez-Llorente, C. (2020). Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials. Nutrients, 12.","DOI":"10.3390\/nu12010124"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00018-015-2061-5","article-title":"Gut microbiota and obesity","volume":"73","author":"Gerard","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","article-title":"Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia","volume":"50","author":"Cani","year":"2007","journal-title":"Diabetologia"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Davani-Davari, D., Negahdaripour, M., Karimzadeh, I., Seifan, M., Mohkam, M., Masoumi, S.J., Berenjian, A., and Ghasemi, Y. (2019). Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications. Foods, 8.","DOI":"10.3390\/foods8030092"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10068-023-01414-x","article-title":"The functional roles of short chain fatty acids as postbiotics in human gut: Future perspectives","volume":"33","author":"Ragavan","year":"2024","journal-title":"Food Sci. Biotechnol."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Vinderola, G., Benkowski, A., Bernardeau, M., Chenoll, E., Collado, M.C., Cronin, U., Eckhardt, E., Green, J.B., Ipharraguerre, I.R., and Kemperman, R. (2025). Postbiotics: A perspective on their quantification. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1582733"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"27679","DOI":"10.1021\/acs.jafc.4c08702","article-title":"Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions","volume":"72","author":"Tiwari","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Vallianou, N.G., Kounatidis, D., Tsilingiris, D., Panagopoulos, F., Christodoulatos, G.S., Evangelopoulos, A., Karampela, I., and Dalamaga, M. (2023). The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076755"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.38212\/2224-6614.3396","article-title":"The next generation beneficial actions of novel probiotics as potential therapeutic targets and prediction tool for metabolic diseases","volume":"30","author":"Cheng","year":"2022","journal-title":"J. Food Drug Anal."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"fuad039","DOI":"10.1093\/femsre\/fuad039","article-title":"Faecalibacterium: A bacterial genus with promising human health applications","volume":"47","author":"Martin","year":"2023","journal-title":"FEMS Microbiol. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","article-title":"Fecal microbiota transplantation: Review and update","volume":"118","author":"Wang","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13099-022-00491-3","article-title":"Adverse events of intestinal microbiota transplantation in randomized controlled trials: A systematic review and meta-analysis","volume":"14","author":"Chen","year":"2022","journal-title":"Gut Pathog."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2020.06.018","article-title":"Fecal microbiota transplantation improves metabolic syndrome parameters: Systematic review with meta-analysis based on randomized clinical trials","volume":"83","author":"Proenca","year":"2020","journal-title":"Nutr. Res."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Qiu, B., Liang, J., and Li, C. (2023). Effects of fecal microbiota transplantation in metabolic syndrome: A meta-analysis of randomized controlled trials. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0288718"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e2247226","DOI":"10.1001\/jamanetworkopen.2022.47226","article-title":"Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients with Obesity Undergoing Bariatric Surgery: A Randomized Clinical Trial","volume":"5","author":"Lahtinen","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: A randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat. Med."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Yu, E.W., Gao, L., Stastka, P., Cheney, M.C., Mahabamunuge, J., Torres Soto, M., Ford, C.B., Bryant, J.A., Henn, M.R., and Hohmann, E.L. (2020). Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial. PLoS Med., 17.","DOI":"10.1371\/journal.pmed.1003051"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"116807","DOI":"10.1016\/j.biopha.2024.116807","article-title":"New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome","volume":"176","author":"Zhao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/19490976.2017.1293224","article-title":"Fecal microbiota transplantation in metabolic syndrome: History, present and future","volume":"8","author":"Frissen","year":"2017","journal-title":"Gut Microbes"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.chom.2017.10.005","article-title":"The Human Microbiome and Obesity: Moving beyond Associations","volume":"22","author":"Maruvada","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized Nutrition by Prediction of Glycemic Responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/s41591-020-0934-0","article-title":"Human postprandial responses to food and potential for precision nutrition","volume":"26","author":"Berry","year":"2020","journal-title":"Nat. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ajcn\/nqz028","article-title":"Model of personalized postprandial glycemic response to food developed for an Israeli cohort predicts responses in Midwestern American individuals","volume":"110","author":"Azulay","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1136\/gutjnl-2022-329201","article-title":"Gut microbiome modulates the effects of a personalised postprandial-targeting (PPT) diet on cardiometabolic markers: A diet intervention in pre-diabetes","volume":"72","author":"Godneva","year":"2023","journal-title":"Gut"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4014\/jmb.2209.09050","article-title":"Personalized Diets based on the Gut Microbiome as a Target for Health Maintenance: From Current Evidence to Future Possibilities","volume":"32","author":"Song","year":"2022","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"e2233760","DOI":"10.1001\/jamanetworkopen.2022.33760","article-title":"Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Low-fat Diet on Weight Loss in Adults with Abnormal Glucose Metabolism and Obesity: A Randomized Clinical Trial","volume":"5","author":"Popp","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/19490976.2016.1270809","article-title":"Linking dietary patterns with gut microbial composition and function","volume":"8","author":"Sheflin","year":"2017","journal-title":"Gut Microbes"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes\/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.","DOI":"10.3390\/nu12051474"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e2412001","DOI":"10.4014\/jmb.2412.12001","article-title":"Advancing Gut Microbiome Research: The Shift from Metagenomics to Multi-Omics and Future Perspectives","volume":"35","author":"Yang","year":"2025","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"G340","DOI":"10.1152\/ajpgi.00440.2001","article-title":"Modulation of lipid synthesis, apolipoprotein biogenesis, and lipoprotein assembly by butyrate","volume":"283","author":"Marcil","year":"2002","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12944-025-02491-z","article-title":"ACSS2 and metabolic diseases: From lipid metabolism to therapeutic target","volume":"24","author":"Hachem","year":"2025","journal-title":"Lipids Health Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tim.2017.11.002","article-title":"Human Gut Microbiome: Function Matters","volume":"26","author":"Wilmes","year":"2018","journal-title":"Trends Microbiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41579-018-0029-9","article-title":"Best practices for analysing microbiomes","volume":"16","author":"Knight","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","article-title":"Human gut microbiome viewed across age and geography","volume":"486","author":"Yatsunenko","year":"2012","journal-title":"Nature"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","article-title":"Environment dominates over host genetics in shaping human gut microbiota","volume":"555","author":"Rothschild","year":"2018","journal-title":"Nature"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41586-020-2881-9","article-title":"Host variables confound gut microbiota studies of human disease","volume":"587","author":"Sklar","year":"2020","journal-title":"Nature"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/14\/1115\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:10:05Z","timestamp":1783678205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/15\/14\/1115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":134,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["biology15141115"],"URL":"https:\/\/doi.org\/10.3390\/biology15141115","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}